Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects.

Hatsukami DK, Luo X, Heskin AK, Tang MK, Carmella SG, Jensen J, Robinson JD, Vandrey R, Drobes DJ, Strasser AA, al'Absi M, Leischow S, Cinciripini PM, Koopmeiners J, Ikuemonisan J, Benowitz NL, Donny EC, Hecht SS.

Addiction. 2019 May 29. doi: 10.1111/add.14695. [Epub ahead of print]

PMID:
31140663
2.

Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.

Carmella SG, Heskin AK, Tang MK, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami DK, Hecht SS.

PLoS One. 2019 Apr 25;14(4):e0215853. doi: 10.1371/journal.pone.0215853. eCollection 2019.

3.

The Late Positive Potentials Evoked by Cigarette-Related and Emotional Images Show no Gender Differences in Smokers.

Stevens EM, Frank D, Codispoti M, Kypriotakis G, Cinciripini PM, Claiborne K, Deweese MM, Engelmann JM, Green CE, Karam-Hage M, Minnix JA, Ng J, Robinson JD, Tyndale RF, Vidrine DJ, Versace F.

Sci Rep. 2019 Mar 1;9(1):3240. doi: 10.1038/s41598-019-39954-0.

4.

Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.

Robinson JD, Li L, Chen M, Lerman C, Tyndale RF, Schnoll RA, Hawk LW, George TP, Benowitz NL, Cinciripini PM.

Psychol Addict Behav. 2019 Mar;33(2):105-116. doi: 10.1037/adb0000434. Epub 2019 Jan 7.

PMID:
30614717
5.

Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein.

Chen M, Carmella SG, Sipe C, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami D, Hecht SS.

PLoS One. 2019 Jan 4;14(1):e0210104. doi: 10.1371/journal.pone.0210104. eCollection 2019.

6.

Withdrawal Symptom, Treatment Mechanism, and/or Side Effect? Developing an Explicit Measurement Model for Smoking Cessation Research.

Tonkin SS, Williams TF, Simms LJ, Tiffany ST, Mahoney MC, Schnoll RA, Cinciripini PM, Hawk LW Jr.

Nicotine Tob Res. 2018 Dec 11. doi: 10.1093/ntr/nty262. [Epub ahead of print]

PMID:
30535357
7.

A tele-mentoring tobacco cessation case consultation and education model for healthcare providers in community mental health centers.

Cofta-Woerpel L, Lam C, Reitzel LR, Wilson W, Karam-Hage M, Beneventi D, Cofer J, Baker E, Wetter DW, Cinciripini PM, Blalock J.

Cogent Med. 2018;5(1). pii: 1430652. doi: 10.1080/2331205X.2018.1430652. Epub 2018 Feb 8.

8.

Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.

Hatsukami DK, Luo X, Jensen JA, al'Absi M, Allen SS, Carmella SG, Chen M, Cinciripini PM, Denlinger-Apte R, Drobes DJ, Koopmeiners JS, Lane T, Le CT, Leischow S, Luo K, McClernon FJ, Murphy SE, Paiano V, Robinson JD, Severson H, Sipe C, Strasser AA, Strayer LG, Tang MK, Vandrey R, Hecht SS, Benowitz NL, Donny EC.

JAMA. 2018 Sep 4;320(9):880-891. doi: 10.1001/jama.2018.11473.

9.

Patterns of Tobacco Product Use and Correlates Among Adults in the Population Assessment of Tobacco and Health (PATH) Study: A Latent Class Analysis.

Kypriotakis G, Robinson JD, Green CE, Cinciripini PM.

Nicotine Tob Res. 2018 Aug 14;20(suppl_1):S81-S87. doi: 10.1093/ntr/nty025.

10.

Robust and Gaussian spatial functional regression models for analysis of event-related potentials.

Zhu H, Versace F, Cinciripini PM, Rausch P, Morris JS.

Neuroimage. 2018 Nov 1;181:501-512. doi: 10.1016/j.neuroimage.2018.07.006. Epub 2018 Jul 6.

PMID:
30057352
11.

The importance of incorporating smoking cessation into lung cancer screening.

Minnix JA, Karam-Hage M, Blalock JA, Cinciripini PM.

Transl Lung Cancer Res. 2018 Jun;7(3):272-280. doi: 10.21037/tlcr.2018.05.03. Review. Erratum in: Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S303.

12.

Randomized trial of a patient-centered decision aid for promoting informed decisions about lung cancer screening: Implementation of a PCORI study protocol and lessons learned.

Lowenstein LM, Escoto KH, Leal VB, Bailey L, Bevers TB, Cantor SB, Cinciripini PM, Jacobs LE, Esparza A, Godoy MC, Housten AJ, Lin H, Luckett P, Munden RF, Rabius V, Volk RJ.

Contemp Clin Trials. 2018 Sep;72:26-34. doi: 10.1016/j.cct.2018.07.007. Epub 2018 Jul 20.

PMID:
30010085
13.

An RCT with the combination of varenicline and bupropion for smoking cessation: clinical implications for front line use.

Cinciripini PM, Minnix JA, Green CE, Robinson JD, Engelmann JM, Versace F, Wetter DW, Shete S, Karam-Hage M.

Addiction. 2018 Apr 21. doi: 10.1111/add.14250. [Epub ahead of print]

PMID:
29679432
14.

Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial.

Yammine L, Kosten TR, Cinciripini PM, Green CE, Meininger JC, Minnix JA, Newton TF.

Medicine (Baltimore). 2018 Jan;97(2):e9567. doi: 10.1097/MD.0000000000009567.

15.

Cigarette cues capture attention of smokers and never-smokers, but for different reasons.

Deweese MM, Codispoti M, Robinson JD, Cinciripini PM, Versace F.

Drug Alcohol Depend. 2018 Apr 1;185:50-57. doi: 10.1016/j.drugalcdep.2017.12.010. Epub 2018 Feb 5.

16.

Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis.

Karam-Hage M, Kypriotakis G, Robinson JD, Green CE, Mann G, Rabius V, Wippold R, Blalock JA, Mouhayar E, Tayar J, Chaftari P, Cinciripini PM.

J Clin Psychopharmacol. 2018 Feb;38(1):34-41. doi: 10.1097/JCP.0000000000000829.

17.

Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study.

Cui Y, Engelmann JM, Xian J, Minnix JA, Lam CY, Karam-Hage M, Cinciripini PM, Robinson JD.

Int J Psychophysiol. 2018 Jan;123:25-34. doi: 10.1016/j.ijpsycho.2017.12.001. Epub 2017 Dec 6.

18.

Brain Responses to Cigarette-Related and Emotional Images in Smokers During Smoking Cessation: No Effect of Varenicline or Bupropion on the Late Positive Potential.

Versace F, Stevens EM, Robinson JD, Cui Y, Deweese MM, Engelmann JM, Green CE, Karam-Hage M, Lam CY, Minnix JA, Wetter DW, Cinciripini PM.

Nicotine Tob Res. 2019 Jan 4;21(2):234-240. doi: 10.1093/ntr/ntx264.

19.

Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration.

Joseph AM, Rothman AJ, Almirall D, Begnaud A, Chiles C, Cinciripini PM, Fu SS, Graham AL, Lindgren BR, Melzer AC, Ostroff JS, Seaman EL, Taylor KL, Toll BA, Zeliadt SB, Vock DM.

Am J Respir Crit Care Med. 2018 Jan 15;197(2):172-182. doi: 10.1164/rccm.201705-0909CI. Review.

20.

Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.

Chenoweth MJ, Ware JJ, Zhu AZX, Cole CB, Cox LS, Nollen N, Ahluwalia JS, Benowitz NL, Schnoll RA, Hawk LW Jr, Cinciripini PM, George TP, Lerman C, Knight J, Tyndale RF; PGRN-PNAT Research Group.

Addiction. 2018 Mar;113(3):509-523. doi: 10.1111/add.14032. Epub 2017 Nov 2.

21.

Mechanisms underlying mindfulness-based addiction treatment versus cognitive behavioral therapy and usual care for smoking cessation.

Spears CA, Hedeker D, Li L, Wu C, Anderson NK, Houchins SC, Vinci C, Hoover DS, Vidrine JI, Cinciripini PM, Waters AJ, Wetter DW.

J Consult Clin Psychol. 2017 Nov;85(11):1029-1040. doi: 10.1037/ccp0000229. Epub 2017 Jun 26.

22.

Beyond Cue Reactivity: Non-Drug-Related Motivationally Relevant Stimuli Are Necessary to Understand Reactivity to Drug-Related Cues.

Versace F, Engelmann JM, Deweese MM, Robinson JD, Green CE, Lam CY, Minnix JA, Karam-Hage MA, Wetter DW, Schembre SM, Cinciripini PM.

Nicotine Tob Res. 2017 Jun 1;19(6):663-669. doi: 10.1093/ntr/ntx002. Review.

23.

Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation.

Robinson JD, Cinciripini PM, Karam-Hage M, Aubin HJ, Dale LC, Niaura R, Anthenelli RM; STRATUS Group.

Addict Biol. 2018 Jan;23(1):291-303. doi: 10.1111/adb.12508. Epub 2017 Apr 21.

24.

Cigarette Nicotine Content as a Moderator of the Relationship Between Negative Affect and Smoking.

Robinson JD, Kypriotakis G, Karam-Hage M, Green CE, Hatsukami DK, Cinciripini PM, Donny EC.

Nicotine Tob Res. 2017 Sep 1;19(9):1080-1086. doi: 10.1093/ntr/ntx068.

25.

Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment.

Cinciripini PM, Green CE, Robinson JD, Karam-Hage M, Engelmann JM, Minnix JA, Wetter DW, Versace F.

Psychopharmacology (Berl). 2017 Jun;234(11):1769-1779. doi: 10.1007/s00213-017-4580-2. Epub 2017 Mar 8.

26.

Tobacco Cessation Treatment Pathways for Patients With Cancer: 10 Years in the Making.

Karam-Hage M, Oughli HA, Rabius V, Beneventi D, Wippold RC, Blalock JA, Cinciripini PM.

J Natl Compr Canc Netw. 2016 Nov;14(11):1469-1477. Review.

27.

Evaluating Point of Sale Tobacco Marketing Using Behavioral Laboratory Methods.

Robinson JD, Drobes DJ, Brandon TH, Wetter DW, Cinciripini PM.

Tob Regul Sci. 2016 Oct;2(4):414-425. doi: 10.18001/TRS.2.4.11.

28.

A brief measure of Smokers' knowledge of lung cancer screening with low-dose computed tomography.

Lowenstein LM, Richards VF, Leal VB, Housten AJ, Bevers TB, Cantor SB, Cinciripini PM, Cofta-Woerpel LM, Escoto KH, Godoy MC, Linder SK, Munden RF, Volk RJ.

Prev Med Rep. 2016 Jul 26;4:351-6. doi: 10.1016/j.pmedr.2016.07.008. eCollection 2016 Dec.

29.

Attentional bias to negative affect moderates negative affect's relationship with smoking abstinence.

Etcheverry PE, Waters AJ, Lam C, Correa-Fernandez V, Vidrine JI, Cinciripini PM, Wetter DW.

Health Psychol. 2016 Aug;35(8):881-890. doi: 10.1037/hea0000338.

30.

Belief about Nicotine Modulates Subjective Craving and Insula Activity in Deprived Smokers.

Gu X, Lohrenz T, Salas R, Baldwin PR, Soltani A, Kirk U, Cinciripini PM, Montague PR.

Front Psychiatry. 2016 Jul 13;7:126. doi: 10.3389/fpsyt.2016.00126. eCollection 2016.

31.

Panic attacks and smoking cessation among cancer patients receiving smoking cessation treatment.

Farris SG, Robinson JD, Zvolensky MJ, Hogan J, Rabius V, Cinciripini PM, Karam-Hage M, Blalock JA.

Addict Behav. 2016 Oct;61:32-9. doi: 10.1016/j.addbeh.2016.05.011. Epub 2016 May 13.

32.

Efficacy of mindfulness-based addiction treatment (MBAT) for smoking cessation and lapse recovery: A randomized clinical trial.

Vidrine JI, Spears CA, Heppner WL, Reitzel LR, Marcus MT, Cinciripini PM, Waters AJ, Li Y, Nguyen NT, Cao Y, Tindle HA, Fine M, Safranek LV, Wetter DW.

J Consult Clin Psychol. 2016 Sep;84(9):824-838.

33.

Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial.

Rabin RA, Ashare RL, Schnoll RA, Cinciripini PM, Hawk LW Jr, Lerman C, Tyndale RF, George TP.

Am J Addict. 2016 Jun;25(4):291-6. doi: 10.1111/ajad.12382. Epub 2016 May 17.

PMID:
27187893
34.

Individual differences in brain responses to cigarette-related cues and pleasant stimuli in young smokers.

Engelmann JM, Versace F, Gewirtz JC, Cinciripini PM.

Drug Alcohol Depend. 2016 Jun 1;163:229-35. doi: 10.1016/j.drugalcdep.2016.04.025. Epub 2016 Apr 25.

35.

Attentional bias to smoking and other motivationally relevant cues is affected by nicotine exposure and dose expectancy.

Robinson JD, Versace F, Engelmann JM, Cui Y, Gilbert DG, Waters AJ, Gritz ER, Cinciripini PM.

J Psychopharmacol. 2016 Jul;30(7):627-40. doi: 10.1177/0269881116642879. Epub 2016 Apr 19.

36.

Research Priorities, Measures, and Recommendations for Assessment of Tobacco Use in Clinical Cancer Research.

Land SR, Toll BA, Moinpour CM, Mitchell SA, Ostroff JS, Hatsukami DK, Duffy SA, Gritz ER, Rigotti NA, Brandon TH, Prindiville SA, Sarna LP, Schnoll RA, Herbst RS, Cinciripini PM, Leischow SJ, Dresler CM, Fiore MC, Warren GW.

Clin Cancer Res. 2016 Apr 15;22(8):1907-13. doi: 10.1158/1078-0432.CCR-16-0104. Epub 2016 Feb 17.

37.

Conditioned cortical reactivity to cues predicting cigarette-related or pleasant images.

Deweese MM, Robinson JD, Cinciripini PM, Versace F.

Int J Psychophysiol. 2016 Mar;101:59-68. doi: 10.1016/j.ijpsycho.2016.01.007. Epub 2016 Jan 28.

38.

Dispositional Mindfulness Predicts Enhanced Smoking Cessation and Smoking Lapse Recovery.

Heppner WL, Spears CA, Correa-Fernández V, Castro Y, Li Y, Guo B, Reitzel LR, Vidrine JI, Mazas CA, Cofta-Woerpel L, Cinciripini PM, Ahluwalia JS, Wetter DW.

Ann Behav Med. 2016 Jun;50(3):337-47. doi: 10.1007/s12160-015-9759-3.

39.

The influence of personality traits on smokers' affect, withdrawal and cessation intervention outcome.

Cui Y, Tang R, Lam CY, Cinciripini PM, Robinson JD.

Addict Behav. 2016 Mar;54:7-11. doi: 10.1016/j.addbeh.2015.11.011. Epub 2015 Nov 26.

40.

Randomized Trial of Reduced-Nicotine Standards for Cigarettes.

Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS, Drobes DJ, Hecht SS, Jensen J, Lane T, Le CT, McClernon FJ, Montoya ID, Murphy SE, Robinson JD, Stitzer ML, Strasser AA, Tindle H, Hatsukami DK.

N Engl J Med. 2015 Oct;373(14):1340-9. doi: 10.1056/NEJMsa1502403.

41.

Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts.

Schwantes-An TH, Zhang J, Chen LS, Hartz SM, Culverhouse RC, Chen X, Coon H, Frank J, Kamens HM, Konte B, Kovanen L, Latvala A, Legrand LN, Maher BS, Melroy WE, Nelson EC, Reid MW, Robinson JD, Shen PH, Yang BZ, Andrews JA, Aveyard P, Beltcheva O, Brown SA, Cannon DS, Cichon S, Corley RP, Dahmen N, Degenhardt L, Foroud T, Gaebel W, Giegling I, Glatt SJ, Grucza RA, Hardin J, Hartmann AM, Heath AC, Herms S, Hodgkinson CA, Hoffmann P, Hops H, Huizinga D, Ising M, Johnson EO, Johnstone E, Kaneva RP, Kendler KS, Kiefer F, Kranzler HR, Krauter KS, Levran O, Lucae S, Lynskey MT, Maier W, Mann K, Martin NG, Mattheisen M, Montgomery GW, Müller-Myhsok B, Murphy MF, Neale MC, Nikolov MA, Nishita D, Nöthen MM, Nurnberger J, Partonen T, Pergadia ML, Reynolds M, Ridinger M, Rose RJ, Rouvinen-Lagerström N, Scherbaum N, Schmäl C, Soyka M, Stallings MC, Steffens M, Treutlein J, Tsuang M, Wall TL, Wodarz N, Yuferov V, Zill P, Bergen AW, Chen J, Cinciripini PM, Edenberg HJ, Ehringer MA, Ferrell RE, Gelernter J, Goldman D, Hewitt JK, Hopfer CJ, Iacono WG, Kaprio J, Kreek MJ, Kremensky IM, Madden PA, McGue M, Munafò MR, Philibert RA, Rietschel M, Roy A, Rujescu D, Saarikoski ST, Swan GE, Todorov AA, Vanyukov MM, Weiss RB, Bierut LJ, Saccone NL.

Behav Genet. 2016 Mar;46(2):151-69. doi: 10.1007/s10519-015-9737-3. Epub 2015 Sep 21.

42.

Black Cigarette Smokers Report More Attention to Smoking Cues Than White Smokers: Implications for Smoking Cessation.

Robinson CD, Pickworth WB, Heishman SJ, Wetter DW, Cinciripini PM, Li Y, Rowell B, Waters AJ.

Nicotine Tob Res. 2015 Aug;17(8):1022-8. doi: 10.1093/ntr/ntu263. Erratum in: Nicotine Tob Res. 2017 Sep 1;19(9):1122.

43.

The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio.

Chenoweth MJ, Schnoll RA, Novalen M, Hawk LW Jr, George TP, Cinciripini PM, Lerman C, Tyndale RF.

Nicotine Tob Res. 2016 Apr;18(4):491-5. doi: 10.1093/ntr/ntv125. Epub 2015 Jun 11.

44.

The Association of Pain With Smoking and Quit Attempts in an Electronic Diary Study of Cancer Patients Trying to Quit.

Aigner CJ, Cinciripini PM, Anderson KO, Baum GP, Gritz ER, Lam CY.

Nicotine Tob Res. 2016 Jun;18(6):1449-55. doi: 10.1093/ntr/ntv118. Epub 2015 Jun 2.

45.

Coping Mediates the Association of Mindfulness with Psychological Stress, Affect, and Depression Among Smokers Preparing to Quit.

Vidrine JI, Businelle MS, Reitzel LR, Cao Y, Cinciripini PM, Marcus MT, Li Y, Wetter DW.

Mindfulness (N Y). 2015 Jun;6(3):433-443. doi: 10.1007/s12671-014-0276-4. Epub 2014 Jan 18.

46.

Testing a Moderated Mediation Model of Mindfulness, Psychosocial Stress, and Alcohol Use among African American Smokers.

Adams CE, Cano MA, Heppner WL, Stewart DW, Correa-Fernández V, Vidrine JI, Li Y, Cinciripini PM, Ahluwalia JS, Wetter DW.

Mindfulness (N Y). 2015 Apr;6(2):315-325.

47.

Reinforcement sensitivity underlying treatment-seeking smokers' affect, smoking reinforcement motives, and affective responses.

Cui Y, Robinson JD, Engelmann JM, Lam CY, Minnix JA, Karam-Hage M, Wetter DW, Dani JA, Kosten TR, Cinciripini PM.

Psychol Addict Behav. 2015 Jun;29(2):300-311. doi: 10.1037/adb0000050. Epub 2015 Jan 26.

48.

Belief about nicotine selectively modulates value and reward prediction error signals in smokers.

Gu X, Lohrenz T, Salas R, Baldwin PR, Soltani A, Kirk U, Cinciripini PM, Montague PR.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2539-44. doi: 10.1073/pnas.1416639112. Epub 2015 Jan 20.

49.

Examination of the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68) Factor Structure in a Sample of Pregnant Smokers.

Parrott CE, Rathnayaka N, Blalock JA, Minnix JA, Cinciripini PM, Vincent JP, Wetter DW, Green C.

Nicotine Tob Res. 2015 Jun;17(6):653-60. doi: 10.1093/ntr/ntu238. Epub 2014 Dec 4.

50.

The motivational salience of cigarette-related stimuli among former, never, and current smokers.

Robinson JD, Versace F, Engelmann JM, Cui Y, Slapin A, Oum R, Cinciripini PM.

Exp Clin Psychopharmacol. 2015 Feb;23(1):37-48. doi: 10.1037/a0038467. Epub 2014 Dec 1.

Supplemental Content

Loading ...
Support Center